Celiac Disease clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 12 years and up
The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
Our lead scientists for Celiac Disease research studies include Guy Weiss.